2010
The role of socioeconomic status in adjustment after ductal carcinoma in situ
de Moor JS, Partridge AH, Winer EP, Ligibel J, Emmons KM. The role of socioeconomic status in adjustment after ductal carcinoma in situ. Cancer 2010, 116: 1218-1225. PMID: 20143325, PMCID: PMC3072709, DOI: 10.1002/cncr.24832.Peer-Reviewed Original ResearchConceptsLow socioeconomic statusSocioeconomic statusDuctal carcinomaSocial supportTime of enrollmentImpact of SESDCIS diagnosisClinical characteristicsLow financial statusClinical depressionPhysical healthStudy periodFinancial statusWomenDepressionLow SESCarcinomaDistressAnxietyDiagnosisHigher financial statusStatusCurrent studyAssociation
2006
Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons
Burstein H, Mayer E, Partridge A, O'Kane H, Litsas G, Come S, Hudis C, Goldstein D, Muss H, Winer E, Garber J. Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons. Clinical Breast Cancer 2006, 7: 158-161. PMID: 16800976, DOI: 10.3816/cbc.2006.n.026.Peer-Reviewed Original ResearchConceptsResidual ovarian functionAromatase inhibitorsAI therapyBreast cancerMenopausal statusOvarian functionEarly-stage breast cancerInadvertent useChemotherapy-related amenorrheaTreatment-related amenorrheaImportant adjunctive therapyPostmenopausal womenPremenopausal womenAdjunctive therapyOvarian reserveTherapyCancerWomenAmenorrheaPatientsInhibitorsStatusCliniciansHormoneCases
2005
Patient Utilities for Advanced Cancer
Wittenberg E, Winer EP, Weeks JC. Patient Utilities for Advanced Cancer. Medical Care 2005, 43: 173-181. PMID: 15655431, DOI: 10.1097/00005650-200502000-00011.Peer-Reviewed Original Research